Neuroprotective properties of citicoline: facts, doubts and unresolved issues - Test2 - elhamkhani - TriplyDB

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

http://www.wikidata.org/entity/Q27021189

about

Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives Post-stroke cognitive impairment: epidemiology, mechanisms and management Therapies targeting lipid peroxidation in traumatic brain injury Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke Citicoline Treatment Improves Measures of Impulsivity and Task Performance in Chronic Marijuana Smokers: A Pilot BOLD fMRI Study.Pharmacotherapy to Enhance Cognitive and Motor Recovery Following Stroke.Citicoline in severe traumatic brain injury: indications for improved outcome : A retrospective matched pair analysis from 14 Austrian trauma centers.Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration.Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function.The choline pathway as a strategy to promote central nervous system (CNS) remyelination.Potential Therapeutics for Vascular Cognitive Impairment and Dementia.Citicoline – a neuroprotector with proven effects on glaucomatous disease.Cytoprotective Effects of Citicoline and Homotaurine against Glutamate and High Glucose Neurotoxicity in Primary Cultured Retinal Cells.Reply: Beneficial effects of exogenous CDP-choline (citicoline) in EAE.Beneficial effects of exogenous CDP-choline (citicoline) in EAE.Lysophosphatidylcholine Drives Neuroblast Cell Fate.[Memantine for optic nerve atrophy in Friedreich's Ataxia].The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.The best basic science paper in multiple sclerosis in 2014: citicoline, remyelination and neuroprotection: commentary.Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration

P2860

Q26775083-60424301-2F53-4983-AEBE-0743243FCCAC Q26781186-30670A5C-6B3B-49E0-B29D-E40D76F65C90 Q26865422-1090D97D-1568-4A94-9B85-F0126C536263 Q28394424-BDF6F601-125E-49BF-9E14-597A8425F5EE Q28829493-2FCAEE53-EC8D-44EC-AC75-D6412B98AFBC Q36361189-65991D90-320E-4F2C-B5B1-84E43C8490BA Q38595982-DF2594BE-F1D8-4699-AB8C-555437FB60E6 Q38656069-C8714374-6C58-46E2-892A-E572DBA128CF Q39357651-3D63C8DC-8021-432F-AD6F-0A20D8BECBDA Q39413668-67F24325-4FC8-425F-B8E0-3D839FB76085 Q43197179-C7813603-CDAF-4868-A081-1047AF076D1C Q45070410-2A265B88-507B-48AD-8CE7-4912E9150756 Q47100745-3F128788-11CF-4094-81A2-617B90949000 Q47147969-A2D2AB97-5CCF-4A71-BCB9-E1E6F35E2DB3 Q48163843-B2548330-3488-43D0-A5F2-458D60409476 Q48163869-04B6650D-4C32-4A19-9F74-6EF666107A33 Q52978029-E813E636-7228-4DD4-A88F-2F58C1636863 Q53249657-865C31D6-0915-4E5E-A483-DC16122607C5 Q53385171-D1BFCD50-AB5D-4177-A008-7D8E1B889A67 Q53610339-F4DD8064-52E2-4ADF-B41E-3FBD65B5442A Q58734085-0658B13E-E239-4E45-B338-FBD21795CCA2

P2860

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

http://www.wikidata.org/entity/Q27021189

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@ast

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@en

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@nl

type

label

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@ast

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@en

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@nl

prefLabel

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@ast

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@en

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@nl

P1433

Q27021189-3B1E5BA0-A7F8-4DF6-9C3F-11857EEEDCEC

P1476

Q27021189-0B496286-A934-492F-98DC-44BA33122CE3

P2093

Q27021189-B76AC71B-0876-4C8D-A805-F52C026A01F6

P2860

Q27021189-0212596D-3688-47EC-BB25-D38C0C54EA12

Q27021189-049B2D8F-F8E1-445B-981C-DB003EA4ADEA

Q27021189-06AE9A12-5D40-4FC7-A61A-E4F00CC806A4

Q27021189-0A683B87-6CA9-4A1C-82D8-A754FDFE0326

Q27021189-0BD55548-2A9E-4C31-97A6-458D9BEDBFD0

Q27021189-0E53BD7D-5859-4EED-AEAD-C89F6A9354DD

Q27021189-1A5EB974-0490-4297-8943-768DD0621934

Q27021189-21BAD1CC-9800-4FA6-89E0-96D59F6EE3CF

Q27021189-22D57F1F-122E-4C41-8301-3B5E28589F79

Q27021189-257A3D6E-0EAE-4142-9ADC-2FCF4CFB22B7

P2888

Q27021189-69900863-A33D-48CD-9F15-2F31877D7E7B

P304

Q27021189-F2B4534E-8B30-468B-B10A-5640A916D72F

P31

Q27021189-370686C9-9137-4B18-8076-270ED56A77C6

P3181

Q27021189-1EC1BD87-D157-4F5D-B75A-961602F454C9

P356

Q27021189-B94E3F74-6864-48F6-9B19-0B7F39497BAD

P407

Q27021189-F415EFBC-0FDB-4C65-AF25-644B45D767A2

P433

Q27021189-E6C0F3DC-6382-4BBC-B783-4615D4B98E2B

P478

Q27021189-2B4FA5E5-CC2E-4D5B-9F1D-C57ADB295E25

P50

Q27021189-71BF6F34-0B0E-41A5-90CE-B2341D5EB658

P577

Q27021189-D6489650-DE3E-4CE8-A713-2C01A28AB7E3

P5875

Q27021189-AB383A85-270C-413F-8906-26A06C31727E

P6179

Q27021189-DEB040D5-6E4C-44CF-A0E1-3E73399DD07A

P698

Q27021189-A9E5877A-396A-42CE-BA5F-36015DE3EC79

P921

Q27021189-08FF65FF-E534-48B6-8D54-456B04443301

Q27021189-ccf26d75-4e94-7733-984f-1ba5b0cd2803

P932

Q27021189-C373F931-1E59-4BAF-8CC6-96228596E480

P3181

P356

S40263-014-0144-8

P1433

P1476

Neuroprotective properties of citicoline: facts, doubts and unresolved issues

@en

P2093

Pawel Grieb

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Choline and betaine intake and the risk of colorectal cancer in men

Choline metabolism and risk of breast cancer in a population-based study

CDP-choline: pharmacological and clinical review

Making the connection: coupling of stress-activated ERK/MAPK (extracellular-signal-regulated kinase/mitogen-activated protein kinase) core signalling modules to extracellular stimuli and biological responses

Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.

Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data.

Interactions among pathways for phosphatidylcholine metabolism, CTP synthesis and secretion through the Golgi apparatus.

Neuroprotection and recovery: recent data at the bench on citicoline.

Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats.

P2888

s40263-014-0144-8

P304

185-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

680787

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S40263-014-0144-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260121615

http://www.w3.org/2001/XMLSchema#string

P6179

1047755148

http://www.w3.org/2001/XMLSchema#string

P698

24504829

http://www.w3.org/2001/XMLSchema#string

P921

CDP-choline (1+)

neuroprotective agent

P932

3933742

http://www.w3.org/2001/XMLSchema#string